Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded
- Contract number
- SPE2DB26FABR4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,926
Award facts
- Contract value 100% obligated
- $27,926.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,926.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 milliliter vials on November 7, 2025, with an ultimate completion date of December 2, 2025. GAMUNEX-C is an intravenous immunoglobulin therapy used to treat immunodeficiency conditions. The contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceuticals and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial federal contract portfolio predominantly with the Defense Logistics Agency and its Medical Supply Chain. The company's federal business spans a diverse range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. As a prime contractor on multiple DLA vehicles, AmerisourceBergen serves critical healthcare customers including the Defense Health Agency and U.S. Coast Guard, demonstrating its capability to meet federal procurement requirements through competitive contracting processes and firm fixed-price delivery mechanisms.
Quick answers
Who was awarded contract SPE2DB26FABR4?
SPE2DB26FABR4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FABR4 worth?
The government has obligated $27,926 on SPE2DB26FABR4.
Is contract SPE2DB26FABR4 an order under another contract?
Yes. SPE2DB26FABR4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FABR4 competed?
The extent of competition for SPE2DB26FABR4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award